Qol Holdings Co., Ltd. (TYO:3034)
Japan
· Delayed Price · Currency is JPY 1,910.00
-23.00 (-1.19%)
May 30, 2025, 3:30 PM JST
Qol Holdings Revenue
In the fiscal year ending March 31, 2025, Qol Holdings had annual revenue of 263.97B JPY with 46.61% growth. Qol Holdings had revenue of 65.77B in the quarter ending March 31, 2025, with 44.46% growth.
Revenue
263.97B
Revenue Growth
+46.61%
P/S Ratio
0.27
Revenue / Employee
45.08M
Employees
5,856
Market Cap
71.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 263.97B | 83.92B | 46.61% |
| Mar 31, 2024 | 180.05B | 10.02B | 5.89% |
| Mar 31, 2023 | 170.04B | 3.84B | 2.31% |
| Mar 31, 2022 | 166.20B | 4.37B | 2.70% |
| Mar 31, 2021 | 161.83B | -3.58B | -2.16% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |